RVL Pharmaceuticals PLC (RVLPQ)
0.00
USD |
OTCM |
May 21, 16:00
RVL Pharmaceuticals Cash and Short Term Investments (Quarterly): 19.16M for June 30, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | 19.16M |
March 31, 2023 | 32.64M |
December 31, 2022 | 44.54M |
September 30, 2022 | 59.75M |
June 30, 2022 | 28.54M |
March 31, 2022 | 28.44M |
December 31, 2021 | 43.51M |
September 30, 2021 | 8.352M |
June 30, 2021 | 99.78M |
March 31, 2021 | 109.21M |
December 31, 2020 | 114.05M |
Date | Value |
---|---|
September 30, 2020 | 126.09M |
June 30, 2020 | 140.38M |
March 31, 2020 | 125.83M |
December 31, 2019 | 95.86M |
September 30, 2019 | 98.01M |
June 30, 2019 | 63.74M |
March 31, 2019 | 63.06M |
December 31, 2018 | 70.83M |
September 30, 2018 | 32.20M |
June 30, 2018 | 28.41M |
December 31, 2017 | 34.74M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
8.352M
Minimum
Sep 2021
140.38M
Maximum
Jun 2020
72.82M
Average
63.74M
Median
Jun 2019
Cash and Short Term Investments (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 1.823M |
Palatin Technologies Inc | 10.01M |
iBio Inc | 5.302M |
Theriva Biologics Inc | 18.26M |
Oragenics Inc | 2.072M |